Idoxuridine in Herpesvirus Encephalitis
- 1 January 1970
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 282 (1) , 47
- https://doi.org/10.1056/nejm197001012820113
Abstract
Although great strides have been made in the development of virus vaccines against some of the major epidemic diseases of man, disappointingly little has been accomplished in the development of antiviral chemotherapy. There are many serious viral illnesses that are not preventable by universal vaccination and probably will not be in the foreseeable future. Herpesvirus encephalitis, the most common cause of sporadic fatal encephalitis in this country, is such a disease. Of 36 patients with this diagnosis recently described by Olson and his associates, 21 died, and all but three survivors had residual effects.1 The illness is characterized by rapid . . .Keywords
This publication has 4 references indexed in Scilit:
- Herpes Simplex Virus Infections of the Nervous SystemArchives of Neurology, 1968
- Herpesvirus Infections of the Human Central Nervous SystemNew England Journal of Medicine, 1967
- Cytomegalovirus syndrome in children with acute leukemia. Treatment with floxuridineJAMA, 1967
- Herpes Simplex Encephalitis Treated with Systemic 5-Iodo-2′deoxyuridineAnnals of Internal Medicine, 1966